URS
CORT icon

Utah Retirement Systems’s Corcept Therapeutics CORT Stock Holding History

Utah Retirement Systems’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Hold
4,968
– – ﹤0.01% 821
2026
Q1 		$200K Buy
+4,968
New +$186K ﹤0.01% 953
2025
Q4 		– Sell
-4,968
Closed -$413K – 986
2025
Q3 		$413K Hold
4,968
– – ﹤0.01% 786
2025
Q2 		$365K Buy
+4,968
New +$360K ﹤0.01% 825

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Utah Retirement Systems's CORT Position: Q2 2026 in Review

Utah Retirement Systems held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 4,968 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #821.

Utah Retirement Systems first reported a position in CORT in Q2 2025 and has held it in 4 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Utah Retirement Systems held 4,968 shares of Corcept Therapeutics worth $432K as of Q2 2026.
  • Utah Retirement Systems left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Utah Retirement Systems's portfolio in Q2 2026, its #821 holding.
  • Utah Retirement Systems first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.